SCHEMBL2309765

SCHEMBL2309765

CNC(=O)c1noc2ccccc12

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 19/20 0.67
CHRNA7 P36544 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29581395 1.00 HIF1A (0.67) HIF1ACHRNA7
SCHEMBL20189383 0.83 HIF1A (0.67) HIF1ACHRNA7
SCHEMBL2310120 0.82 HIF1A (0.61) HIF1A
SCHEMBL3434886 0.80 HIF1A (0.61) HIF1A
SCHEMBL28970683 0.80 HIF1A (1.00) HIF1A
SCHEMBL30615702 0.79 HIF1A (0.61) HIF1A
SCHEMBL496601 0.78 HIF1A (0.65) HIF1A
SCHEMBL3526062 0.78 LMNA (0.46) HIF1A
SCHEMBL22424047 0.78 LMNA (0.46) HIF1A
SCHEMBL29580510 0.78 HIF1A (0.60) HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350077-A1 FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AstraZeneca AB (SE) 2011-08-03 EP disclosed
WO-2010043893-A1 FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2010-04-22 WO disclosed